Inducible Enhancement of T Cell Function and Anti-tumor Activity after Adoptive Transfer

被引:1
|
作者
Wrangle, John [1 ]
Paulos, Chrystal M. [2 ,3 ]
Smith, Thomas W., Jr. [4 ]
Nishimura, Michael I. [4 ]
Rubinstein, Mark P. [5 ,6 ,7 ]
机构
[1] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA
[3] Med Univ South Carolina, Dept Dermatol, Charleston, SC 29425 USA
[4] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Dept Surg, 2160 S 1st Ave,Bldg 112,Room 308, Maywood, IL 60153 USA
[5] Med Univ South Carolina, Hollings Canc Ctr, Dept Surg, 86 Jonathan Lucas St,Room 506, Charleston, SC 29425 USA
[6] Med Univ South Carolina, Hollings Canc Ctr, Dept Microbiol, 86 Jonathan Lucas St,Room 506, Charleston, SC 29425 USA
[7] Med Univ South Carolina, Hollings Canc Ctr, Dept Immunol, 86 Jonathan Lucas St,Room 506, Charleston, SC 29425 USA
关键词
ANTIGEN RECEPTOR; CANCER; THERAPY; IMMUNOTHERAPY; DYSFUNCTION; EXHAUSTION; MELANOMA; TUMORS;
D O I
10.1016/j.ymthe.2017.08.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1995 / 1996
页数:2
相关论文
共 50 条
  • [41] Pparβ/d Has an Indispensable Role in T Cell Function and Anti-Tumor Responses
    Ibis, Betul
    Christofides, Anthos
    Aliazis, Konstantinos
    Shah, Rushil
    Pal, Rinku
    Boussiotis, Vassiliki A.
    BLOOD, 2023, 142
  • [42] ANTI-TUMOR ACTIVITY OF A NEW ANTI-TUMOR ANTIBIOTIC, STUBOMYCIN
    KOMIYAMA, K
    EDANAMI, KI
    YAMAMOTO, H
    UMEZAWA, I
    JOURNAL OF ANTIBIOTICS, 1982, 35 (06): : 703 - 706
  • [43] EFFECTIVE ANTI-TUMOR IMMUNITY FOLLOWING ELIMINATION OF SUPPRESSOR T-CELL FUNCTION
    FALK, RE
    NOSSAL, NA
    FALK, JA
    SURGERY, 1978, 84 (04) : 483 - 489
  • [44] Induction of remission results in spontaneous enhancement of anti-tumor cytotoxic T-lymphocyte activity in dogs with B cell lymphoma
    Mitchell, L.
    Dow, S. W.
    Slansky, J. E.
    Biller, B. J.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2012, 145 (3-4) : 597 - 603
  • [45] Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function
    Tian, Chenxi
    Wang, Yu
    Su, Miya
    Huang, Yuanyuan
    Zhang, Yuwei
    Dou, Jiaxiang
    Zhao, Changfeng
    Cai, Yuting
    Pan, Jun
    Bai, Shiyu
    Wu, Qielan
    Chen, Sanwei
    Li, Shuhang
    Xie, Di
    Lv, Rong
    Chen, Yusheng
    Wang, Yucai
    Fu, Sicheng
    Zhang, Huimin
    Bai, Li
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [46] Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function
    Chenxi Tian
    Yu Wang
    Miya Su
    Yuanyuan Huang
    Yuwei Zhang
    Jiaxiang Dou
    Changfeng Zhao
    Yuting Cai
    Jun Pan
    Shiyu Bai
    Qielan Wu
    Sanwei Chen
    Shuhang Li
    Di Xie
    Rong Lv
    Yusheng Chen
    Yucai Wang
    Sicheng Fu
    Huimin Zhang
    Li Bai
    Nature Communications, 15
  • [47] Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity
    Chen, Yonglin
    Jia, Manxue
    Wang, Sharon
    Xu, Sherry
    He, Nanhai
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Coenzyme A fuels T cell anti-tumor immunity
    St Paul, Michael
    Saibil, Samuel D.
    Han, SeongJun
    Israni-Winger, Kavita
    Lien, Scott C.
    Laister, Rob C.
    Sayad, Azin
    Penny, Susanne
    Amaria, Rodabe N.
    Haydu, Lauren E.
    Garcia-Batres, Carlos R.
    Kates, Meghan
    Mulder, David T.
    Robert-Tissot, Celine
    Gold, Matthew J.
    Tran, Charles W.
    Elford, Alisha R.
    Nguyen, Linh T.
    Pugh, Trevor J.
    Pinto, Devanand M.
    Wargo, Jennifer A.
    Ohashi, Pamela S.
    CELL METABOLISM, 2021, 33 (12) : 2415 - +
  • [49] Decreased tumor surveillance after adoptive T cell therapy
    Matter, Matthias
    Pavelic, Viktor
    Pinschewer, Danial D.
    Mumprecht, Sabine
    Eschli, Bruno
    Giroglou, Tsanan
    von Laer, Dorothee
    Ochsenbein, Adrian F.
    CANCER RESEARCH, 2007, 67 (15) : 7467 - 7476
  • [50] Intratumor adoptive transfer of IL-12 mRNA transiently engineered anti-tumor CD8+T cells
    Etxeberria, Inaki
    Bolanos, Elixabet
    Teijeira, Alvaro
    Azpilicueta, Arantza
    Ignacio Quetglas, Jose
    Rodriguez Sanchez-Paulete, Alfonso
    Otano, Itziar
    Mancheno, Uxua
    Hervas-Stubbs, Sandra
    Inoges, Susana
    Garasa, Saray
    Alvarez, Maite
    Berraondo, Pedro
    Melero, Ignacio
    CANCER RESEARCH, 2019, 79 (13)